search
Back to results

Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators

Primary Purpose

Diabetes Mellitus Type 1

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
Accu-Chek Combo Kit mg DE/de
Sponsored by
Hoffmann-La Roche
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional diagnostic trial for Diabetes Mellitus Type 1

Eligibility Criteria

18 Years - undefined (Adult, Older Adult)All Sexes

Inclusion Criteria:

  • Subjects >/= 18 years at screening
  • Type 1 diabetics currently using an insulin pump for management of their diabetes and have been on a pump for at least at least 6 months prior to the screening visit
  • Subjects have to use a fast acting analog insulin
  • HbA1c = 9% (measured with DCA 2000)
  • Willing to perform periods of intensive blood glucose (BG) monitoring for up to 21 days prior to the study (~10 tests per day) with skipped meals and testmeals
  • Willing to use the 3 different bolus calculators during the course of the study
  • Willing to undergo planned hyperglycemia
  • Willing to perform high frequency BG monitoring (> 20 / day) during the experiment

Exclusion Criteria:

  • Type 2 Diabetes
  • Manifest severe late complications of diabetes (e.g. severe macro- or microangiopathy, severe neuropathy, severe retinopathy and/or severe nephropathy)
  • Current addiction to alcohol or substances of abuse
  • Pregnant or lactating women
  • Any known life-threatening disease

Sites / Locations

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

Single Arm

Arm Description

Outcomes

Primary Outcome Measures

To compare the difference between the self-monitoring blood glucose (SMBG) value achieved at 6 hours after meals with induced post-prandial hyperglycemia and the mean target value of 110 mg/dL. Target post-prandial range is 80-140 mg/dL.

Secondary Outcome Measures

To compare the absolute difference between the SMBG value and the target value between the calculators
To compare theto compare the relative difference (multiplied by 100) between the SMBG value and the target value between the calculators
To compare the absolute relative difference (RAD, multiplied by 100) between the SMBG value and the target value between the calculators

Full Information

First Posted
January 15, 2010
Last Updated
March 1, 2016
Sponsor
Hoffmann-La Roche
search

1. Study Identification

Unique Protocol Identification Number
NCT01050868
Brief Title
Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators
Study Type
Interventional

2. Study Status

Record Verification Date
January 2011
Overall Recruitment Status
Completed
Study Start Date
June 2009 (undefined)
Primary Completion Date
December 2009 (Actual)
Study Completion Date
December 2009 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Hoffmann-La Roche

4. Oversight

5. Study Description

Brief Summary
This prospective, non-randomized, non-controlled, interventional study will determine whether the Roche automated bolus caclulator (ABC) reduces post-meal hyperglycemia better than the competitor's ABC without causing significant hypoglycemia.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Diabetes Mellitus Type 1

7. Study Design

Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
Non-Randomized
Enrollment
24 (Actual)

8. Arms, Groups, and Interventions

Arm Title
Single Arm
Arm Type
Experimental
Intervention Type
Device
Intervention Name(s)
Accu-Chek Combo Kit mg DE/de
Primary Outcome Measure Information:
Title
To compare the difference between the self-monitoring blood glucose (SMBG) value achieved at 6 hours after meals with induced post-prandial hyperglycemia and the mean target value of 110 mg/dL. Target post-prandial range is 80-140 mg/dL.
Time Frame
6 hours after meal
Secondary Outcome Measure Information:
Title
To compare the absolute difference between the SMBG value and the target value between the calculators
Time Frame
6 hours after meal
Title
To compare theto compare the relative difference (multiplied by 100) between the SMBG value and the target value between the calculators
Time Frame
6 hours after meal
Title
To compare the absolute relative difference (RAD, multiplied by 100) between the SMBG value and the target value between the calculators
Time Frame
6 hours after meal

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Eligibility Criteria
Inclusion Criteria: Subjects >/= 18 years at screening Type 1 diabetics currently using an insulin pump for management of their diabetes and have been on a pump for at least at least 6 months prior to the screening visit Subjects have to use a fast acting analog insulin HbA1c = 9% (measured with DCA 2000) Willing to perform periods of intensive blood glucose (BG) monitoring for up to 21 days prior to the study (~10 tests per day) with skipped meals and testmeals Willing to use the 3 different bolus calculators during the course of the study Willing to undergo planned hyperglycemia Willing to perform high frequency BG monitoring (> 20 / day) during the experiment Exclusion Criteria: Type 2 Diabetes Manifest severe late complications of diabetes (e.g. severe macro- or microangiopathy, severe neuropathy, severe retinopathy and/or severe nephropathy) Current addiction to alcohol or substances of abuse Pregnant or lactating women Any known life-threatening disease
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Bettina Petersen
Organizational Affiliation
Roche Diagnostics GmbH / Diabetes Care
Official's Role
Study Director
Facility Information:
City
Ulm
ZIP/Postal Code
89081
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Comparison of the Management of Post-prandial Hyperglycemia by Multiple Bolus Calculators

We'll reach out to this number within 24 hrs